跳至主要内容
临床试验/ACTRN12605000146695
ACTRN12605000146695已完成4 期

Randomised controlled trial of antivenom for the treatment of pain in redback spider bite; intravenous versus intramuscular antivenom.

Geoff Isbister0 个研究点目标入组 400 人开始时间: 2005年8月15日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
8 Years 至 ot stated(—)
性别
All

入选标准

  • (1) definite redback spider-bite and the spider is identified by the patient or clinician at the time of the bite; OR (2) clinical syndrome that is consistent with typical redback envenoming; AND the treating clinician would normally treat the patient with antivenom, namely: - moderate envenoming = severe local pain without systemic envenoming- severe envenoming = severe local pain and systemic features.

排除标准

  • 1. Patients who have received antivenom for this envenoming prior to enrolment2. Children aged <8 years 3. Bite occurring >24 hours ago

研究者

发起方
Geoff Isbister

相似试验

Redback Spider AntiVenom Evaluation (RAVE) Study | 临床试验